{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:55:40Z","timestamp":1767984940366,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.taap.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T06:02:29Z","timestamp":1484719349000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models"],"prefix":"10.1016","volume":"318","author":[{"given":"Shujie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2936-2617","authenticated-orcid":false,"given":"Hiroshi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.01.006_bb0005","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.24493","article-title":"Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity","volume":"54","author":"Ahmed","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2017.01.006_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20071944","article-title":"Development of all CD4 T lineages requires nuclear factor TOX","volume":"205","author":"Aliahmad","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2017.01.006_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/01926230490440934","article-title":"Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies","volume":"32","author":"Allen","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2017.01.006_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2012.06574.x","article-title":"Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis","volume":"1259","author":"Brigelius-Floh\u00e9","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2017.01.006_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10408444.2013.835787","article-title":"Mode of action and dose-response framework analysis for receptor-mediated toxicity: the aryl hydrocarbon receptor as a case study","volume":"44","author":"Budinsky","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2017.01.006_bb0030","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1289\/ehp.971051196","article-title":"The significance of mouse liver tumor formation for carcinogenic risk assement: results and conclusions from a survey of ten years testing by the agrochemical industry","volume":"105","author":"Carmichael","year":"1997","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2017.01.006_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2017.01.006_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biocel.2015.05.019","article-title":"The novel secretory protein CGREF1 inhibits the activation of AP-1 transcriptional activity and cell proliferation","volume":"65","author":"Deng","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.taap.2017.01.006_bb0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2017.01.006_bb0050","author":"FAO\/WHO"},{"key":"10.1016\/j.taap.2017.01.006_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0015-6264(65)80129-8","article-title":"Liver response tests. III. Liver enlargement and stimulation of microsomal processing enzyme activity","volume":"3","author":"Gilbert","year":"1965","journal-title":"Food Cosmet. Toxicol."},{"key":"10.1016\/j.taap.2017.01.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102579","article-title":"Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action","volume":"9","author":"Gusenleitner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.01.006_bb0065","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0192623312448935","article-title":"Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes-conclusions from the 3rd international ESTP expert workshop","volume":"40","author":"Hall","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2017.01.006_bb0070","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3892\/ol.2016.4117","article-title":"TOX3 protein expression is correlated with pathological characteristics in breast cancer","volume":"11","author":"Han","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2017.01.006_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/00401706.2000.10485983","article-title":"Ridge regression: biased problems nonorthogonal estimation for","volume":"42","author":"Hoerl","year":"2000","journal-title":"Technometrics"},{"key":"10.1016\/j.taap.2017.01.006_bb0080","doi-asserted-by":"crossref","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","author":"Igarashi","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2017.01.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070675","article-title":"Role of PPAR\u03b1 and HNF4\u03b1 in stress-mediated alterations in lipid homeostasis","volume":"8","author":"Konstandi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.01.006_bb0090","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1158\/0008-5472.CAN-08-1343","article-title":"Evidence for an important role of CIDEA in human cancer cachexia","volume":"68","author":"Laurencikiene","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2017.01.006_bb0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3892\/or.2014.3237","article-title":"Asparagine synthetase expression and its potential prognostic value in patients with NK\/T cell lymphoma","volume":"32","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2017.01.006_bb0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2017.01.006_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4137\/CIN.S3229","article-title":"Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration","volume":"7","author":"Matsumoto","year":"2009","journal-title":"Cancer Informat."},{"key":"10.1016\/j.taap.2017.01.006_bb0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.toxrep.2014.10.014","article-title":"Toxicity prediction from toxicogenomic data based on class association rule mining","volume":"1","author":"Nagata","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.taap.2017.01.006_bb0115","doi-asserted-by":"crossref","first-page":"832712","DOI":"10.1155\/2014\/832712","article-title":"A critical role for ZDHHC2 in metastasis and recurrence in human hepatocellular carcinoma","volume":"2014","author":"Peng","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2017.01.006_bb0120","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/carcin\/18.11.2029","article-title":"Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643","volume":"18","author":"Peters","year":"1997","journal-title":"Carcinogenesis"},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2017.01.006_bb0125","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2105-7-S1-S9","article-title":"Learning interpretable SVMs for biological sequence classification","volume":"7","author":"R\u00e4tsch","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.taap.2017.01.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097640","article-title":"Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat","volume":"9","author":"R\u00f6mer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.01.006_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0009-2797(80)90017-4","article-title":"Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth","volume":"31","author":"Schulte-Hermann","year":"1980","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2017.01.006_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11010-016-2776-0","article-title":"Differential expression of store-operated calcium- and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing","volume":"420","author":"Selli","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2017.01.006_bb0145","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/sj.onc.1209394","article-title":"Hepatocellular carcinoma in Txnip-deficient mice","volume":"25","author":"Sheth","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2017.01.006_bb0150","article-title":"ALDH1B1 is crucial for colon tumorigenesis by modulating Wnt\/\u03b2-catenin, Notch and PI3K\/Akt signaling pathways","volume":"10","author":"Singh","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2017.01.006_bb0155","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.bjc.6605936","article-title":"PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer","volume":"103","author":"Su","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2017.01.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2004.02.003","article-title":"Toxicogenomics in predictive toxicology in drug development","author":"Suter","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.taap.2017.01.006_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2013.07.005","article-title":"Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis","volume":"311","author":"Suzuki","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2017.01.006_bb0175","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2017.01.006_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"key":"10.1016\/j.taap.2017.01.006_bb0190","author":"U.S. EPA"},{"key":"10.1016\/j.taap.2017.01.006_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.taap.2011.07.001","article-title":"Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database","volume":"255","author":"Uehara","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.01.006_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mrgentox.2012.04.011","article-title":"Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR","volume":"747","author":"Watanabe","year":"2012","journal-title":"Mutat. Res. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.taap.2017.01.006_bb0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/jf60130a015","article-title":"Safety evaluation of chemicals, relationship between short-and long-term feeding studies in designing an effective toxicity test","volume":"11","author":"Weil","year":"1963","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2017.01.006_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365521.2016.1190399","article-title":"Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells","volume":"51","author":"Yu","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.taap.2017.01.006_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2017.01.006_bb0220","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/acsmedchemlett.5b00153","article-title":"Suppression of hepatocellular carcinoma by inhibition of overexpressed ornithine aminotransferase","volume":"6","author":"Zigmond","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.taap.2017.01.006_bb0225","doi-asserted-by":"crossref","first-page":"524101","DOI":"10.1155\/2014\/524101","article-title":"Phosphoglycerate dehydrogenase: potential therapeutic target and putative metabolic oncogene","volume":"2014","author":"Zogg","year":"2014","journal-title":"J. Oncol."},{"key":"10.1016\/j.taap.2017.01.006_bb0230","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-015-3633-9","article-title":"Differential expression of ion channels and transporters during hepatocellular carcinoma development","volume":"60","author":"Z\u00fa\u00f1iga-Garc\u00eda","year":"2015","journal-title":"Dig. Dis. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17300261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17300261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T21:45:18Z","timestamp":1719006318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17300261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":44,"alternative-id":["S0041008X17300261"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.01.006","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}